Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Cystine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Nihon Rikagaku
    Japan
    		 Nippon Rika Pharmaceuticals Co., Ltd. 219MF10338 Japanese Pharmacopoeia L-Cysteine 2007-11-21 2007-11-21 2-2 Nihonbashi Honcho 4-chome, Chuo-ku, Tokyo
    26/09/2024 Nippon Protein Co Ltd
    Japan
    		 Nippon Protein Co., Ltd. 218MF11012 Extra-official regulation L-cystine (for manufacturing ... 2006-12-18 2006-12-18 575 Shimada-cho, Ashikaga City, Tochigi Prefecture